Efficacy and Safety of Imatinib in Scleroderma
NCT00479934
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Scleroderma, Localized
Scleroderma, Systemic
Interventions
DRUG:
imatinib mesylate
Sponsor
University Hospital, Bordeaux
Collaborators
[object Object]
[object Object]